The surgical management of small bowel neuroendocrine tumors

James R. Howe, Kenneth Cardona, Douglas L. Fraker, Electron Kebebew, Brian R. Untch, Yi Zarn Wang, Calvin H. Law, Eric H. Liu, Michelle K. Kim, Yusuf Menda, Brian G. Morse, Emily K. Bergsland, Jonathan R. Strosberg, Eric K. Nakakura, Rodney Pommier

    Research output: Contribution to journalReview article

    31 Citations (Scopus)

    Abstract

    Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and surgical oncologists are seeing more patients with SBNETs in their practices than ever before. The management of these patients is often complex, owing to their secretion of hormones, frequent presentation with advanced disease, and difficulties with making the diagnosis of SBNETs. Despite these issues, even patients with advanced disease can have long-Term survival. There are a number of scenarios which commonly arise in SBNET patients where it is difficult to determine the optimal management from the published data. To address these challenges for clinicians, a consensus conference was held assembling experts in the field to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from these studies and the recommendations of the group for these questions regarding the management of SBNET patients.

    Original languageEnglish (US)
    Pages (from-to)715-731
    Number of pages17
    JournalPancreas
    Volume46
    Issue number6
    DOIs
    StatePublished - 2017

    Fingerprint

    Neuroendocrine Tumors
    Hormones
    Survival
    Neoplasms

    Keywords

    • Carcinoid tumors
    • Carcinomatosis
    • DOTATATE
    • Hepatic debulking
    • Liver metastases
    • Octreotide prophylaxis
    • Small bowel tumors
    • Unknown primary NET
    • Video capsule endoscopy

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Hepatology
    • Endocrinology

    Cite this

    Howe, J. R., Cardona, K., Fraker, D. L., Kebebew, E., Untch, B. R., Wang, Y. Z., ... Pommier, R. (2017). The surgical management of small bowel neuroendocrine tumors. Pancreas, 46(6), 715-731. https://doi.org/10.1097/MPA.0000000000000846

    The surgical management of small bowel neuroendocrine tumors. / Howe, James R.; Cardona, Kenneth; Fraker, Douglas L.; Kebebew, Electron; Untch, Brian R.; Wang, Yi Zarn; Law, Calvin H.; Liu, Eric H.; Kim, Michelle K.; Menda, Yusuf; Morse, Brian G.; Bergsland, Emily K.; Strosberg, Jonathan R.; Nakakura, Eric K.; Pommier, Rodney.

    In: Pancreas, Vol. 46, No. 6, 2017, p. 715-731.

    Research output: Contribution to journalReview article

    Howe, JR, Cardona, K, Fraker, DL, Kebebew, E, Untch, BR, Wang, YZ, Law, CH, Liu, EH, Kim, MK, Menda, Y, Morse, BG, Bergsland, EK, Strosberg, JR, Nakakura, EK & Pommier, R 2017, 'The surgical management of small bowel neuroendocrine tumors', Pancreas, vol. 46, no. 6, pp. 715-731. https://doi.org/10.1097/MPA.0000000000000846
    Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ et al. The surgical management of small bowel neuroendocrine tumors. Pancreas. 2017;46(6):715-731. https://doi.org/10.1097/MPA.0000000000000846
    Howe, James R. ; Cardona, Kenneth ; Fraker, Douglas L. ; Kebebew, Electron ; Untch, Brian R. ; Wang, Yi Zarn ; Law, Calvin H. ; Liu, Eric H. ; Kim, Michelle K. ; Menda, Yusuf ; Morse, Brian G. ; Bergsland, Emily K. ; Strosberg, Jonathan R. ; Nakakura, Eric K. ; Pommier, Rodney. / The surgical management of small bowel neuroendocrine tumors. In: Pancreas. 2017 ; Vol. 46, No. 6. pp. 715-731.
    @article{882a0d49e2fe46328e44738feda639f1,
    title = "The surgical management of small bowel neuroendocrine tumors",
    abstract = "Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and surgical oncologists are seeing more patients with SBNETs in their practices than ever before. The management of these patients is often complex, owing to their secretion of hormones, frequent presentation with advanced disease, and difficulties with making the diagnosis of SBNETs. Despite these issues, even patients with advanced disease can have long-Term survival. There are a number of scenarios which commonly arise in SBNET patients where it is difficult to determine the optimal management from the published data. To address these challenges for clinicians, a consensus conference was held assembling experts in the field to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from these studies and the recommendations of the group for these questions regarding the management of SBNET patients.",
    keywords = "Carcinoid tumors, Carcinomatosis, DOTATATE, Hepatic debulking, Liver metastases, Octreotide prophylaxis, Small bowel tumors, Unknown primary NET, Video capsule endoscopy",
    author = "Howe, {James R.} and Kenneth Cardona and Fraker, {Douglas L.} and Electron Kebebew and Untch, {Brian R.} and Wang, {Yi Zarn} and Law, {Calvin H.} and Liu, {Eric H.} and Kim, {Michelle K.} and Yusuf Menda and Morse, {Brian G.} and Bergsland, {Emily K.} and Strosberg, {Jonathan R.} and Nakakura, {Eric K.} and Rodney Pommier",
    year = "2017",
    doi = "10.1097/MPA.0000000000000846",
    language = "English (US)",
    volume = "46",
    pages = "715--731",
    journal = "Pancreas",
    issn = "0885-3177",
    publisher = "Lippincott Williams and Wilkins",
    number = "6",

    }

    TY - JOUR

    T1 - The surgical management of small bowel neuroendocrine tumors

    AU - Howe, James R.

    AU - Cardona, Kenneth

    AU - Fraker, Douglas L.

    AU - Kebebew, Electron

    AU - Untch, Brian R.

    AU - Wang, Yi Zarn

    AU - Law, Calvin H.

    AU - Liu, Eric H.

    AU - Kim, Michelle K.

    AU - Menda, Yusuf

    AU - Morse, Brian G.

    AU - Bergsland, Emily K.

    AU - Strosberg, Jonathan R.

    AU - Nakakura, Eric K.

    AU - Pommier, Rodney

    PY - 2017

    Y1 - 2017

    N2 - Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and surgical oncologists are seeing more patients with SBNETs in their practices than ever before. The management of these patients is often complex, owing to their secretion of hormones, frequent presentation with advanced disease, and difficulties with making the diagnosis of SBNETs. Despite these issues, even patients with advanced disease can have long-Term survival. There are a number of scenarios which commonly arise in SBNET patients where it is difficult to determine the optimal management from the published data. To address these challenges for clinicians, a consensus conference was held assembling experts in the field to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from these studies and the recommendations of the group for these questions regarding the management of SBNET patients.

    AB - Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and surgical oncologists are seeing more patients with SBNETs in their practices than ever before. The management of these patients is often complex, owing to their secretion of hormones, frequent presentation with advanced disease, and difficulties with making the diagnosis of SBNETs. Despite these issues, even patients with advanced disease can have long-Term survival. There are a number of scenarios which commonly arise in SBNET patients where it is difficult to determine the optimal management from the published data. To address these challenges for clinicians, a consensus conference was held assembling experts in the field to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from these studies and the recommendations of the group for these questions regarding the management of SBNET patients.

    KW - Carcinoid tumors

    KW - Carcinomatosis

    KW - DOTATATE

    KW - Hepatic debulking

    KW - Liver metastases

    KW - Octreotide prophylaxis

    KW - Small bowel tumors

    KW - Unknown primary NET

    KW - Video capsule endoscopy

    UR - http://www.scopus.com/inward/record.url?scp=85020842465&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85020842465&partnerID=8YFLogxK

    U2 - 10.1097/MPA.0000000000000846

    DO - 10.1097/MPA.0000000000000846

    M3 - Review article

    VL - 46

    SP - 715

    EP - 731

    JO - Pancreas

    JF - Pancreas

    SN - 0885-3177

    IS - 6

    ER -